Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cecors Inc (OP: CEOS )

0.0471 -0.0029 (-5.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 243,807
Open 0.0494
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0500
Today's Range 0.0455 - 0.0497
52wk Range 0.0101 - 0.0977
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CeCors Completes Acquisition of VetComm Corp, Expanding into the Multibillion-dollar Veteran's Benefits Industry
Via ACCESSWIRE
CeCors Finalizes Terms with VetComm to Enter the Multi-Billion Dollar Veteran Benefits Industry
McapMediaWire - CECORS, INC. (OTC: CEOS) ("CeCors" or the "Company"), is pleased to provide corporate highlights from the final quarter of fiscal 2022 and an update to the earlier press release dated... 
Via TheNewswire.com

Performance

YTD
+218.24%
+218.24%
1 Month
-45.86%
-45.86%
3 Month
+262.31%
+262.31%
6 Month
+20.77%
+20.77%
1 Year
-27.54%
-27.54%

More News

Read More
CeCors Finalizes Terms with VetComm to Enter the Multi-Billion Dollar Veteran Benefits Industry
Via News Direct
PsyKey, Inc. Announces Veteran Corporate Executive & Scientific Innovator John Gustin as Head of Global Business Development
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
CeCors Inc. Corporate Update
Via ACCESSWIRE
PsyKey, Inc. Announces Veteran Corporate Executive & Scientific Innovator John Gustin as Head of Global Business Development
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
PsyKey Inc Announces Distribution & Product Development Agreement with National Lifestyle & Wellness Distributer Hygeia LLC
Via ACCESSWIRE
PsyKey Inc Announces Beta Testing of its Telemental Health App Aimed to Aid in North America’s $330 Billion Mental Health Crisis
Via ACCESSWIRE
PsyKey Inc. Prepares to Enter $23 Billion Global Box Subscription Market With its Functional Mushroom Products
Via ACCESSWIRE
CeCors, Inc. Issues Statement Regarding Unauthorized Stock Promotion
Via ACCESSWIRE
CeCors, Inc. Issues Statement Regarding Unauthorized Stock Promotion
From CeCors, Inc.
Via AccessWire
PsyKey Inc. Announces Fulfillment of Purchase Order for its Functional Mushroom Infused Coffee
Via ACCESSWIRE
PsyKey Inc. Announces Fulfillment of Purchase Order for its Functional Mushroom Infused Coffee
From CeCors, Inc.
Via AccessWire
PsyKey Inc. Introduces Its Premium Functional Mushroom Infused Coffee Line to the $8 Billion Dollar Functional Mushroom Market, Through the Launch of Its New E-Commerce Website
From CeCors, Inc.
Via AccessWire
PsyKey Expands Product Portfolio in the $8 Billion Dollar Functional Mushroom Market with the Acquisition of NutraRox
From CeCors, Inc.
Via AccessWire
PsyKey, Inc., Achieves Key Revenue Milestone With Purchase Order Of Its Functional Mushroom Products
From CeCors, Inc.
Via AccessWire
PsyKey, Inc. Corporate Update
From CeCors, Inc.
Via AccessWire
PsyKey Inc. Announces Discussions with Biotechnology Company & Psilocybin Fermentation Specialist, Zealous Inc.
From CeCors, Inc.
Via AccessWire
PsyKey Inc. Appoints Mental Health Professional Ms. Tessa Lawlor, B.A, M.A. to its Strategic Advisory Board
From CeCors, Inc.
Via AccessWire
Topics Death
Exposures Death
PsyKey Inc Announces Partnership with The Professional Gardener Co LTD to Develop and Distribute Innovative Products Designed for the Mushroom Production and Organic Farming Markets
From CeCors, Inc.
Via AccessWire
PsyKey Inc Completes Definitive Agreement with MycoVita to establish a Strategic Partnership focused on Research, Development and Commercialization of Mycology based Products
From CeCors, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.